Novartis Pharmaceuticals Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Novartis Pharmaceuticals and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 15000 Novartis Pharmaceuticals employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Novartis Pharmaceuticals has purchased the following applications: H1 HealthCare Data Platform for Analytics and BI in 2018, Serrala FinanceSuite Accounts Payable for AP Automation in 2015, Amazon EC2 for Application Hosting and Computing Services in 2020 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Novartis Pharmaceuticals is running and its propensity to invest more and deepen its relationship with H1 Insights , Serrala , Easy Access AP or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Novartis Pharmaceuticals revenues, which have grown to $12.00 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Novartis Pharmaceuticals intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.